Description
Laboratories screening for multiple biomarkers demand a platform that gives more data without more cost or labor.  xMAP technology offers a multiplex solution that boosts laboratory productivity in biomarker screening.  xMAP is a ‘liquid ELISA’ approach, enabling multiplexing of up to 100 analytes per sample well. In addition to research, xMAP technology is ideal for diagnostic applications in clinical labs, as it allows for multi-analyte profiles with the ability to build internal controls into the various assays. Luminex's breakthrough approach offers comparable sensitivity to traditional ELISA-based systems, but with additional advantages including multiplexing, extended dynamic range, smaller sample size, and dramatically reduced workload.

Tests available from:

EMD/Merck (Novagen)  
Millipore Corporation (LINCO & Upstate)  
Rules Based Medicine